TQH3821 Tablets

TQH3821 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQH3821 Tablets, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis [Phase 2]